Headless WordPress - PROD

Plasma biomarkers enable early diagnosis and promote patient retention

https://www.sharecare.com/hcp/neurology/early-alzheimers-detection-blood-based-biomarkers

Closing the diagnostic gap: Advancing early Alzheimer’s detection through blood-based biomarkers

Improving early detection through collaborative care and standardized assessment

https://www.sharecare.com/hcp/neurology/equipping-primary-care-recognize-preclinical-alzheimers-presentations

Redefining the referral pathway: Equipping primary care to recognize preclinical Alzheimer's presentations

Understanding where patients disengage to improve care continuity

https://www.sharecare.com/hcp/neurology/alzheimers-care-critical-intervention-points-neurologists

Navigating patient attrition in the Alzheimer's care journey: Critical intervention points for neurologists|Supporting caregivers as partners in managing agitation in Alzheimer's disease|Clinical frameworks for assessment and management of agitation in Alzheimer’s disease|Neurobiological mechanisms underlying agitation in Alzheimer's disease|

Navigating patient attrition in the Alzheimer's care journey: Critical intervention points for neurologists

Identifying executive, visuospatial, language, and behavioral impairments

https://www.sharecare.com/hcp/neurology/recognizing-non-amnestic-presentations-early-alzheimers-disease

Beyond memory complaints: Recognizing non-amnestic presentations of early Alzheimer's disease

Featured Content

Dx Dialogues: Alzheimer's Disease

Watch as Dr. Parker explores blood-based biomarkers and diagnostic clarity in Alzheimer's disease and related disorders.